| Patents for C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306) |
|---|
| 02/10/1994 | DE4226102A1 Balhimycin glycopeptide derivs. - with good antibacterial properties, esp. against gram positive bacteria, including methicillin resistant Staphylococci |
| 02/01/1994 | US5283353 Enzymeric cleavage from glycoprotein |
| 11/25/1993 | WO1993023542A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 11/25/1993 | CA2134326A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 11/18/1993 | EP0465481B1 New substituted alkylamide derivatives of teicoplanin |
| 11/16/1993 | US5262312 Etherification with hydroxy containing protected amine acid derivative |
| 11/11/1993 | WO1993021948A1 Peptide-carbohydrate conjugates generating t-cell immunity |
| 11/11/1993 | CA2134097A1 Peptide-carbohydrate conjugates generating t-cell immunity |
| 11/03/1993 | CN1077961A Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds |
| 11/02/1993 | US5258495 Process for making vancomycin HC1 |
| 11/02/1993 | US5258362 Enzyme inhibitors, amides with oxetane ring |
| 10/28/1993 | WO1993021207A1 Process for making vancomycin |
| 10/02/1993 | WO1993020105A1 Complexes of the peptidoglycan monomer (pgm) with trivalent metals, process for the manufacture thereof and their use |
| 10/02/1993 | CA2133087A1 Complexes of the peptidoglycan monomer (pgm) with trivalent metals, process for the manufacture thereof and their use |
| 09/29/1993 | EP0561827A1 Tetrapeptides deriving from dalbaheptide antibiotics. |
| 09/16/1993 | WO1993016087A3 Amadori reaction compounds and products, process for their manufacture, and their use |
| 09/15/1993 | EP0276278B1 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 09/08/1993 | EP0558961A2 Glycopeptide derivatives, process for their manufacture and pharmaceutical compositions comprising them |
| 09/06/1993 | CA2091024A1 Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds |
| 08/25/1993 | EP0556292A1 Hepatitis c virus asialoglycoproteins |
| 08/25/1993 | EP0483271B1 Peptides containing diamino-glycols as transition-state mimics |
| 08/19/1993 | WO1993016087A2 Amadori reaction compounds and products, process for their manufacture, and their use |
| 08/19/1993 | CA2130106A1 Amadori reaction compounds and products, process for their manufacture, and their use |
| 08/18/1993 | EP0555385A1 Agents and methods for binding to elam-1 |
| 08/10/1993 | US5235037 Adding alkali or alkaline earth metal inorganic salt |
| 08/10/1993 | US5234904 For food and drinks |
| 07/27/1993 | CA1320795C Process for recovery of glycopeptidic antibiotics |
| 07/14/1993 | EP0551107A2 Method for a beta-galactosidase catalyzed transglycosilation with non-physiological glycosyl-donors |
| 07/13/1993 | CA1320312C Improved vancomycin precipitation process |
| 07/10/1993 | CA2086972A1 Process for .beta.-galactosidase-catalyzed transglycosidation with unphysiological glycosyl donors |
| 07/08/1993 | WO1993013121A1 Gapped 2' modified oligonucleotides |
| 07/06/1993 | US5225529 Synthetic amphiphilic glycoconjugates for neurological use |
| 06/29/1993 | US5223413 Process for the preparation of vancomycin |
| 06/16/1993 | EP0547029A1 Immunogen and its use for preparing antibodies to HbA1c |
| 06/16/1993 | EP0546115A1 Peptides containing amino-polyols as transition-state mimics |
| 06/16/1993 | CN1021228C Improved vancomycin precipitation process |
| 06/10/1993 | WO1993011254A1 Protease-stable proteins |
| 06/10/1993 | CA2124316A1 Protease-stable proteins |
| 06/09/1993 | EP0545352A1 Pharmaceutical compositions containing Lactobacillus casei peptidoglycan |
| 06/09/1993 | EP0545198A2 Peptides with insulin like activity |
| 05/27/1993 | WO1993010148A1 Muramyl compounds for treatment of septic shock |
| 05/26/1993 | EP0331756B1 Agents for prophylaxis and treatment of thrombopenia |
| 05/25/1993 | US5213797 Excellent activity against grampositive bacteria; increased feed-utilization efficiency and improved weight gains in animals |
| 05/18/1993 | US5212161 Antitumor |
| 05/18/1993 | CA1317900C Antibiotic a 40926 complex and its pure factors pa, pb, a, b, and b |
| 05/12/1993 | CN1020616C Process for preparing de-(acetylglucosaminyl)-di (dehydro)-deoxyteicoplanin derivatives |
| 05/11/1993 | US5210072 Immunomodulant, suppressing IgE formation |
| 05/04/1993 | US5208218 T cell growth factor glycoproteins |
| 04/14/1993 | EP0536671A2 Carboxylic acid ester protecting groups, process to prepare them, their coupling to functional groups and their use |
| 04/08/1993 | CA2079921A1 Carboxylate protective groups, a process for their preparation, their coupling to a functional group, and their use |
| 03/30/1993 | US5198418 Substituted alkylamides of teicoplanin compounds |
| 03/30/1993 | CA1315470C Allylic side chain-containing solid phase systems, processes for the preparation thereof and the use thereof in solid phase reactions |
| 03/30/1993 | CA1315231C Kibdelosporangium aridum sk&f-aad-609 |
| 03/24/1993 | EP0532915A2 Phosphoinositolglycan-peptide with insulin like activity |
| 03/16/1993 | CA1314656C Analogs of gonadoliberin with improved solubility, methods for their preparation, agents containing them and their use |
| 03/10/1993 | EP0530887A1 Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases |
| 03/09/1993 | US5192742 Antibiotics |
| 03/04/1993 | WO1993003746A1 Preparation of medicaments containing the peptidoglycan monomer or its derivatives |
| 03/04/1993 | CA2115270A1 The use of the peptidoglycan monomer (pgm), its n-acyl derivatives, and its metal complexes in the preparation of medicaments for the correction of the immunosuppressive and hepatosuppressive states of the organism |
| 02/24/1993 | EP0528117A2 Vancomycin precipitation process |
| 02/23/1993 | US5189023 Hypotensive agent |
| 02/23/1993 | US5189017 Use of sugar derivatives for the prophylaxis and treatment of virus infections |
| 02/18/1993 | WO1993003060A1 Amide derivatives of antibiotic a 40926 |
| 02/18/1993 | WO1993003037A1 Organic nitrates, methods for preparing same and use thereof for treating cardiovascular diseases |
| 02/18/1993 | CA2113922A1 Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases |
| 02/16/1993 | US5187082 Cultivating Amycolatopsis albus or mutant under submerged aerobic fermentation |
| 02/09/1993 | US5185320 O56 -alkyl derivatives of aglycone and pseudo aglycones of teicoplanin |
| 02/03/1993 | EP0525499A1 Amide derivatives of antibiotic A 40926 |
| 01/07/1993 | EP0521408A1 Glycopeptide antibiotics derivated from balhimycin |
| 01/07/1993 | DE4121662A1 New balhimycin derivs. obtd. from Actinomyces Y-86,21022 |
| 12/30/1992 | CA2072725A1 Glycopeptides, a process for their preparation and their use |
| 12/23/1992 | WO1992022313A1 Renin inhibiting compounds |
| 12/23/1992 | CN1067249A Amidinophenylalanine derivatives and process for preparing same and use |
| 12/08/1992 | US5169934 Intracellularly cleavable compounds |
| 12/01/1992 | CA1311086C Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 11/26/1992 | WO1992020703A1 The use of nucleic acid analogues in diagnostics and analytical procedures |
| 11/26/1992 | WO1992020702A1 Peptide nucleic acids |
| 11/26/1992 | CA2109805A1 The use of nucleic acid analogues in diagnostics and analytical procedures |
| 11/19/1992 | EP0513543A1 Derivatives of amidinophenylalanine, procedure for their preparation, their utilisation and anticoagulant compositions comprising them. |
| 11/17/1992 | US5164484 De-(acetylglucosaminyl-di(dehydro)-deoxy teicoplanin derivatives |
| 11/12/1992 | WO1992019248A1 High affinity mannose receptor ligands |
| 11/12/1992 | CA2068263A1 Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants |
| 10/20/1992 | US5157112 Antibodies immunoreactive with the T-cell growth factor, P40 |
| 10/15/1992 | WO1992017495A1 Antibiotic a 40926 ester derivatives |
| 10/13/1992 | CA1308711C Derivatives of monophosphoryl lipid a and process for preparation |
| 10/06/1992 | US5153312 Respiratory system disorders |
| 10/06/1992 | US5153173 N-acyl derivatives of the peptidoglycan monomer, pharmaceutically acceptable salts thereof, their preparation and use as immunomodulators and immunoadjuvants |
| 09/30/1992 | EP0505735A1 Antibiotic A 40926 ester derivatives |
| 09/22/1992 | US5149784 Elution of culture; through ion exchange resin basification, crystallizing, separation; salt foramtion with hydrochloric acid |
| 09/16/1992 | EP0503301A2 Peptide derivatives and application thereof |
| 09/02/1992 | EP0501250A1 Fucose-marked batracylin derivatives |
| 08/28/1992 | CA2061993A1 Fucose-bearing cytostatics |
| 08/27/1992 | CA2060746A1 Manufacture of calcium hydrosilicate bound fiberboard |
| 08/19/1992 | EP0340245B1 Substituted alkylamides of teicoplanin compounds |
| 08/04/1992 | US5135857 Transforming teichoplanins with cultures of Nocardia orientalis or Streptomyces candidus |
| 07/29/1992 | EP0268678B1 Novel 5-fluorouridine compounds and process for their preparation |
| 07/22/1992 | EP0327548B1 Glycopeptide antibiotics |
| 07/21/1992 | US5132286 Composition of antibiotic l 17054 and a method for the treatment of bacterial infections using the antibiotic |
| 07/15/1992 | CN1062735A T-butyloxycarbonyl-l-tyrosyl-peptidoglycan monomer and 125 i-labelled derivative thereof, their preparation and use |
| 07/09/1992 | WO1992011288A1 Hexapeptides deriving from aglucoteicoplanin and a process for preparing them |